Skip to content

Howard Hughes Medical Institute: ORCL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Howard Hughes Medical Institute on ORCL, newest first. How the timeline and the estimate are built.

Howard Hughes Medical Institute held 23,851 ORCL shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 23,851 shares
    Change vs previous 13F 0 shares

    0.78% of the 13F portfolio, value $3,495,364.

    13F-HR 0001193125-26-350254 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 23,851 shares
    Change vs previous 13F +23,491 shares

    0.84% of the 13F portfolio, value $3,508,721.

    13F-HR 0001193125-26-225362 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 360 shares
    Change vs previous 13F +5 shares

    0.04% of the 13F portfolio, value $70,168.

    13F-HR 0001193125-26-052983 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 355 shares
    Change vs previous 13F +5 shares

    0.06% of the 13F portfolio, value $99,840.

    13F-HR 0001193125-25-281376 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 350 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $76,521.

    13F-HR 0000950123-25-007937 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).